Ligand validation:2FO0

MYR: MYRISTIC ACID

MYR is a Ligand Of Interest in 2FO0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2FO0_MYR_A_701	7%	53%	0.295	0.762	1.07	0.76	1	1	1	0	94%	0.9375
1OPK_MYR_A_1	2%	44%	0.285	0.518	1	1.15	2	2	2	0	100%	1
1OPL_MYR_A_538	0%	70%	1.056	0.647	0.57	0.59	-	-	3	0	94%	0.9375
6NOK_MYR_A_401	92%	52%	0.077	0.967	0.71	1.14	-	2	0	0	100%	1
7OWO_MYR_D_401	88%	73%	0.088	0.962	0.45	0.59	-	-	0	0	100%	0.525
7OWU_MYR_C_101	84%	69%	0.106	0.967	0.53	0.66	-	-	1	0	100%	0.9375
5O9U_MYR_C_101	81%	64%	0.111	0.964	0.58	0.8	-	-	0	0	100%	0.9375
4L8U_MYR_A_602	77%	60%	0.116	0.957	0.58	0.95	-	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.